News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,046 Results
Type
Article (14769)
Company Profile (67)
Press Release (269207)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (101582)
Career Advice (469)
Deals (15533)
Drug Delivery (102)
Drug Development (37286)
Employer Resources (51)
FDA (6516)
Job Trends (6306)
News (151860)
Policy (14238)
Tag
2025 Best Places to Work (7)
2026 Best Places to Work (13)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
40 Under 40 (2)
Academia (475)
Accelerated approval (34)
ADA (11)
Adcomms (9)
Allergies (117)
Alliances (23414)
ALS (87)
Alzheimer's disease (601)
Antibody-drug conjugate (ADC) (240)
Approvals (6989)
Artificial intelligence (357)
ASCO (114)
Autoimmune disease (118)
Automation (26)
Bankruptcy (155)
Belgium (6)
Best Places to Work (4423)
BIO (26)
Biologics (49)
BIOSECURE Act (9)
Biosimilars (199)
BioSpace Insights (72)
Biotechnology (30)
Bispecific (15)
Bladder cancer (73)
Brain cancer (46)
Breast cancer (259)
Cancer (2151)
Cardiovascular disease (252)
Career advice (431)
Career pathing (15)
CAR-T (81)
CDC (11)
CDMO (101)
Celiac Disease (1)
Cell therapy (236)
Cervical cancer (25)
Clinical research (33631)
Collaboration (1151)
Commercialization (38)
Company closure (3)
Compensation (483)
Complete response letters (54)
COVID-19 (854)
CRISPR (68)
CRO (4)
C-suite (859)
Cystic fibrosis (68)
Data (3354)
Decentralized trials (2)
Denatured (19)
Depression (68)
Dermatology (41)
Diabetes (205)
Diagnostics (1548)
Digital health (19)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (215)
Drug pricing (126)
Drug shortages (16)
Duchenne muscular dystrophy (121)
Earnings (35137)
Editorial (25)
Employer branding (4)
Employer resources (47)
ESMO (127)
Events (40939)
Executive appointments (707)
Eye disease (4)
FDA (8326)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (4)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (669)
Gene editing (105)
Generative AI (38)
Gene therapy (241)
GLP-1 (533)
Government (1465)
Grass and pollen (4)
Guidances (179)
Healthcare (3727)
Hematology (77)
HIV (23)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (72)
Immunology and inflammation (104)
Immuno-oncology (46)
Indications (141)
Infectious disease (976)
Inflammatory bowel disease (98)
Inflation Reduction Act (7)
Influenza (35)
Intellectual property (169)
Interviews (60)
IPO (5968)
IRA (33)
Job creations (2063)
Job search strategy (378)
JPM (29)
Kidney cancer (19)
Kidney disease (61)
Labor market (50)
Layoffs (227)
Leadership (14)
Legal (3464)
Licensing (81)
Liver cancer (30)
Longevity (18)
Lung cancer (311)
Lung diease (5)
Lymphoma (188)
Machine learning (17)
Management (18)
Manufacturing (771)
Marketing (21)
MASH (106)
Medical affairs (3)
Medical device (1347)
Medtech (1376)
Melanoma (58)
Mergers & acquisitions (10213)
Metabolic disorders (675)
Middle East (1)
mRNA (81)
Multiple sclerosis (78)
Multispecific (1)
NASH (15)
Netherlands (7)
Neurodegenerative disease (152)
Neuropsychiatric disorders (57)
Neuroscience (1276)
Neurotech (2)
NextGen: Class of 2026 (1591)
Non-profit (619)
Now hiring (31)
Obesity (344)
Opinion (158)
Ovarian cancer (83)
Pain (168)
Pancreatic cancer (86)
Parkinson's disease (130)
Partnered (15)
Patents (348)
Patient advocacy (2)
Patient recruitment (242)
Patient selection (33)
Peanut (18)
People (30819)
Peptides (19)
Pharmaceutical (34)
Pharmacy benefit managers (20)
Phase 1 (8677)
Phase 2 (14190)
Phase 3 (12878)
Pipeline (5299)
Policy (167)
Postmarket research (1414)
Preclinical (3483)
Press Release (25)
Prostate cancer (135)
Psychedelics (32)
Radioligand (1)
Radiopharmaceuticals (193)
Rare diseases (612)
Real estate (2674)
Recruiting (19)
Regenerative medicine (7)
Regulatory (12042)
Reports (24)
Research institute (596)
Resumes & cover letters (55)
Rett syndrome (18)
RNA editing (10)
RSV (29)
Saudi Arabia (1)
Schizophrenia (105)
Series A (134)
Series B (75)
Series C (1)
Service/supplier (1)
Sickle cell disease (68)
Special edition (15)
Spinal muscular atrophy (86)
Sponsored (13)
Startups (1666)
State (2)
Stem cells (2)
Stomach cancer (8)
Substance use disorders (7)
Supply chain (79)
Switzerland (13)
Tariffs (72)
The Weekly (57)
Vaccines (328)
Venture capital (57)
Weight loss (193)
Wet AMD (4)
Women's health (69)
Worklife (5)
Date
Today (51)
Last 7 days (281)
Last 30 days (1253)
Last 365 days (10817)
2026 (9904)
2025 (10832)
2024 (12599)
2023 (14387)
2022 (19732)
2021 (20219)
2020 (19109)
2019 (14935)
2018 (11734)
2017 (13940)
2016 (13161)
2015 (15512)
2014 (12445)
2013 (10614)
2012 (11424)
2011 (11971)
2010 (10944)
Location
Africa (328)
Alabama (25)
Alaska (1)
Arizona (111)
Arkansas (4)
Asia (21711)
Australia (2810)
California (4764)
Canada (2141)
China (964)
Colorado (211)
Connecticut (208)
Delaware (227)
Europe (43018)
Florida (898)
Georgia (92)
Hawaii (2)
Idaho (11)
Illinois (549)
India (105)
Indiana (381)
Iowa (3)
Japan (460)
Kansas (93)
Kentucky (23)
Louisiana (9)
Maine (2)
Maryland (599)
Massachusetts (3825)
Michigan (60)
Minnesota (250)
Mississippi (2)
Missouri (41)
Montana (9)
Nebraska (8)
Nevada (38)
New Hampshire (13)
New Jersey (2173)
New Mexico (7)
New York (1373)
North Carolina (872)
North Dakota (2)
Northern California (2312)
Ohio (117)
Oklahoma (6)
Oregon (17)
Pennsylvania (1030)
Puerto Rico (23)
Rhode Island (19)
South America (510)
South Carolina (16)
Southern California (2114)
Tennessee (84)
Texas (668)
United States (18864)
Utah (78)
Vermont (1)
Virginia (252)
Washington D.C. (42)
Washington State (350)
West Virginia (1)
Wisconsin (78)
Wyoming (2)
284,046 Results for "sequel pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
February 19, 2026
·
7 min read
Press Releases
Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions
June 8, 2026
·
5 min read
Policy
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, announced its partner, DEKA Research & Development Corp., has received 510 clearance from the U.S. Food and Drug Administration for the innovative twiist™ Automated Insulin Delivery system powered by Tidepool.
March 18, 2024
·
4 min read
Press Releases
Sequel Med Tech to Integrate twiist Automated Insulin Delivery (AID) System with Abbott’s Future Dual Glucose-Ketone Sensor
May 22, 2025
·
3 min read
FDA
Sequel Spiral™ Tampon Receives FDA Approval as Medical Device
Sequel, a startup, dedicated to engineering better health and wellness experiences for women, today announced that its breakthrough spiral tampon has received approval from the United States Food and Drug Administration (FDA) as a medical device.
August 15, 2023
·
3 min read
Press Releases
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
April 29, 2025
·
7 min read
Pharm Country
Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at CTAD
Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) announced that Willem de Haan, M.D., Ph.D., a neurologist and senior researcher at the Amsterdam University Medical Centers’ Alzheimer Center, is presenting complete EEG findings from the Phase 2 SEQUEL study at the Clinical Trials on Alzheimer’s Disease (CTAD) conference. SEQUEL was conducted at the Amsterdam UMC in the Netherlands with Everard (Jort) Vijverberg, M.D., Ph.D., acting as principal investigator.
October 24, 2023
·
7 min read
Press Releases
Acadia Pharmaceuticals Enters Exclusive Distribution Agreement with KYORIN Pharmaceutical for DAYBUE® STIX (trofinetide) in Japan
November 16, 2026
·
4 min read
Press Releases
ConV2X Releases Final Agenda Focused on AI, Clinical Development, FDA Regulation and Pharmaceutical Data Integrity
ConV2X Releases Final Agenda Focused on AI, Clinical Development, FDA Regulation and Pharmaceutical Data Integrity
September 8, 2026
·
1 min read
Press Releases
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
November 19, 2026
·
3 min read
1 of 28,405
Next